03:48

Understanding smoldering pathology in MS

02:30

Etiology-specific treatment approach in neonatal status epilepticus

02:07

Opioid use in patients with medication overuse headache

03:23

Psychological support needs for people with phenylketonuria

04:19

Skin innervation as a prognostic biomarker in ALS

03:58

Characterizing double-negative NMOSD

06:48

Impact of parental smoking on MS risk

03:21

Diagnosing narcolepsy: the revised classification of CNS hypersomnolence disorders

03:59

Repurposing MS and NMOSD treatments for CIDP

05:00

The gut microbiome in restless leg syndrome: searching for novel biomarkers

05:25

Education in autonomic medicine in Europe

03:01

The current treatment landscape for myasthenia gravis

03:19

Autonomic markers for the differential diagnosis of pure autonomic failure

03:00

Palliative care in severe epileptic conditions

03:21

How to approach the classification of neuromuscular disorders

03:02

Current diagnostic criteria exclude many pediatric patients with probable migraine

01:24

Formation of the AHS autonomic disorders special interest section

02:58

Preventive treatment approach in pediatric migraine

01:10

POTS, hEDS, and migraine: shedding light on the connections

02:57

Research goals from the American Headache Society

02:04

Diagnosing autonomic function disorders in patients with headache

01:36

Investigating disparities in the care of pediatric headache

02:45

High placebo response in pediatric headache clinical trials

02:02

Potential of delta opioid receptors as a target for migraine

01:48

CGRP monoclonal antibody use in Japan

03:03

Dysautonomia in patients with migraine

02:01

Developing delta opioid receptor agonists for migraine treatment

02:03

The impact of estrogen exposure on vascular risk in women with migraine

04:25

Lidocaine occipital nerve blocks found to be effective in treating status migrainosus in children

03:33

The challenges and opportunities of using AI in medicine

01:31

Discussing patient priorities for ALS research

03:34

UK perspective: cost-effectiveness of gene therapies for ALS

02:28

The role of TDP-43 in ALS pathology

04:32

Antisense oligonucleotides for C9orf72-associated ALS: explaining the lack of success

01:08

Lessons in patience gained from the tofersen clinical trials

10:28

Progress in genetic therapies for ALS

04:12

Biomarkers for the diagnosis of Parkinson’s disease

02:02

Neuro-Neonatal Intensive Care Unit (Neuro-NICU) models

02:42

Proactive management to reduce postpartum relapses in MS

02:07

REM sleep behavior disorder and its link to α-synucleinopathy

02:51

Diagnostic performance of paramagnetic rim lesions, cortical lesions, and the central vein sign

02:22

Peripherin as a biomarker for ALS

01:44

Features of status epilepticus in neonates vs older children

03:50

Headache with visual symptoms: red flags in the work-up

01:34

Childbirth and neonatal outcomes in myasthenia gravis

04:03

Treating patients with long-term neurological conditions

02:04

What is medication overuse headache?

01:09

Improving thrombectomy triage in urban areas

01:28

Exciting developments in sleep research

01:15

Advocating for enhanced education on FND diagnosis

01:40

Barriers to thrombectomy treatment in stroke patients

03:21

Reasons for success in the ENRICH trial of minimally invasive surgery for ICH

01:09

Developing a career in neurology and global health

02:14

Developments in ALS biomarker research: the ALL ALS consortium

01:33

Holistic approaches to FND treatment

01:04

Metabolism and response to anti-CGRP treatments in migraine

02:34

Effect of daylight savings time on sleep

04:35

Defining distinct cognitive phenotypes in multiple sclerosis

07:23

NLP algorithm to extract headache frequency from clinical notes

01:43

Advances in subdural hematoma management